ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 12 filers reported holding ENDOLOGIX INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $28,000 | – | 29,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 5,000,000 | $4,488,000 | 2.19% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 21,240,000 | $18,932,000 | 0.69% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,625,000 | $7,694,000 | 0.16% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,785,000 | $8,725,000 | 0.14% |
| AVIVA PLC | 5,000,000 | $4,469,000 | 0.04% |
| AMUNDI ASSET MANAGEMENT US, INC. | 7,305,000 | $6,557,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,000,000 | $901,000,000 | 0.02% |
| Polar Capital LLP | 700,000 | $628,000 | 0.01% |
| Citadel Advisors | 12,000,000 | $10,738,000 | 0.01% |
| Orbimed Advisors | 1,000,000 | $898,000 | 0.01% |